-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701.O2.6 701. Experimental Transplantation: Basic and Translational: GVHD, GVL and Alloimmunity

Symposia: Experimental Transplantation: Basic and Translational Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Immune mechanism, Diseases, Immunology, Adverse Events, Lymphoid Malignancies, Computational biology, Biological Processes, Myeloid Malignancies, Molecular biology, Technology and Procedures, Study Population, Human, Omics technologies
Monday, December 9, 2024: 2:45 PM-4:15 PM
Room 6B (San Diego Convention Center)
Moderators:
Antiopi Varelias, PhD, QIMR Berghofer Medical Research Institute and Tomomi Toubai, MD, PhD, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Kulvara Kittisares, MD1,2*, Pietro Crivello, PhD1*, Thorben Walther1*, Maryam Mohamaddokht1,3*, Thuja Arrieta Bolaños, PhD1*, Luisa Betke, PhD1*, Dominik Lux4*, Thilo Bracht, PhD4,5*, Malte Bayer, PhD4,5*, Sarah Flossdorf6*, Effie Wang Petersdorf, MD7*, Amin T. Turki, MD1,8*, Peter Horn, MD9*, Johannes Köster, PhD10*, Astrid M. Westendorf, PhD11*, J.H. Frederik Falkenburg, MD, PhD12, Marieke Griffioen, PhD12*, Barbara Sitek, PhD4,5*, Thomas Schroeder13*, Marie Bleakley, PhD, MBBS, MMSc7, Katharina Fleischhauer, MD1,14* and Esteban Arrieta-Bolanos14,15*

1Institute for Experimental Cellular Therapy, University Hospital Essen, Essen, Germany
2Department of Transfusion Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
3Institute of Neurophysiology, Charité Universitätsmedizin Berlin, Berlin, Germany
4Medical Proteome Center, Center for Protein Diagnostics (PRODI), Ruhr University Bochum, Bochum, Germany
5Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany
6Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University of Duisburg-Essen, Essen, Germany
7Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
8Institute for AI in Medicine, University Hospital Essen, Essen, Germany
9Institute for Transfusion Medicine, University Hospital Essen, Essen, Germany
10Bioinformatics and Computational Oncology, Institute for Artificial Intelligence in Medicine (IKIM), University of Duisburg-Essen, Essen, Germany
11Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Esse, Essen, Germany
12Hematology, Leiden University Medical Center, Leiden, Netherlands
13Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
14German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Essen, Germany
15Institute for Experimental Cellular Therapy, Essen University Hospital, Essen, Germany

3:00 PM

Yumika Saito, MD1*, Daigo Hashimoto, MD2, Keisuke Kojima, MD1*, Shihori Tsukamoto, MD1*, Tomoe Ichiki, MD1*, Toru Miyajima, MD3*, Wenyu Li1*, Shinpei Harada, MD1*, Zixuan Zhang1*, Hajime Senjo, MD4, Yuta Hasegawa, MD, PhD1*, Takahide Ara, MD, PhD1* and Takanori Teshima, MD, PhD1

1Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
2Department of Hematology, Hokkaido University, Sapporo, Japan
3Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, HOK, Japan
4Department of Hematology, Hokkaido University, Kita-Ku, Japan

3:15 PM

Hajime Senjo, MD1,2, Daigo Hashimoto, MD3, Shihori Tsukamoto, MD4*, Keisuke Kojima, MD4*, Shimpei I Kubota, MD, PhD5*, Ayumu Ito, MD, PhD6*, Tomoe Ichiki, MD4*, Satomi Okada, MD4*, Yumika Saito, MD4*, Toru Miyajima, MD7*, Shinpei Harada, MD4*, Wenyu Li4*, Zixuan Zhang4*, Yuta Hasegawa, MD, PhD4*, Hiroyuki Ohigashi, MD, PhD8*, Takahide Ara, MD, PhD4*, Yoshinori Hasegawa, PhD9*, Yoshihiro Inamoto, MD, PhD10, Masaaki Murakami, VMD, PhD5*, Takahiro Fukuda6* and Takanori Teshima, MD, PhD11

1Department of Hematology, Hokkaido University, Kita-Ku, Japan
2Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan
3Department of Hematology, Hokkaido University, Sapporo, Japan
4Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan
5Molecular Psychoneuroimmunology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
6Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
7Department of Hematology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, HOK, Japan
8Department of Hematology, Hokkaido University Hospital, Sapporo, HOK, JPN
9Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan
10Department of Blood and Marrow Transplantation and Cellular Therapy, Fujita Health University, Aichi, Japan
11Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan

3:30 PM

Ruowen Wei1*, Ao Zhang2*, Moran Wang, PhD2*, Xie-Na Cao, PhD2*, Ruiqi Zhu, PhD2*, Shengling Ma, MD, PhD3, Linghui Xia2* and Wei Shi, PhD2*

1Institute of Hematology, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Hubei, China
2Institute of Hematology, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China
3Section of Hematology-Oncology, Baylor College of Medicine, HOUSTON, TX

3:45 PM

Motoko Koyama, MD, PhD1, Shuichiro Takahashi, MD, PhD2,3*, Takayuki Inoue, MD, PhD3,4*, Kathleen S Ensbey3*, Samuel R. W. Legg3*, Tomoko Sekiguchi3*, Ethan Nelson3*, Nicole S Nemychenkov3*, Tanvi Joshi3*, Simone A Minnie, PhD1, Albert C Yeh, MD3,5, Julie R Boiko, MD, MS3,5, Ping Zhang, MD3,6*, Mark B Headley, PhD3*, Jisun Paik, PhD7*, John K Amory, MD8* and Geoffrey R. Hill, MD3,5

1Translational Sciences and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
2Division of Hematology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan
3Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
4Division of Respiratory Medicine and Hematology, Hyogo Medical University, Nishinomiya, Japan
5University of Washington, Seattle, WA
6QIMR Berghofer Medical Research Institute, Brisbane, Australia
7Department of Comparative Medicine, University of Washington, Seattle, WA
8Department of Medicine, University of Washington, Seattle, WA

4:00 PM

Gaelen Dwyer, MD, PhD1,2, Lisa Mathews1*, Bailey Chalmers1*, Afsana Naaz, PhD3*, Amanda Poholek, PhD3*, Craig Byersdorfer, MD1,4, Faruk Sacirbegovic, PhD3*, Warren Shlomchik, MD5 and Heth Turnquist, PhD3*

1University of Pittsburgh, Pittsburgh, PA
2University of Michigan, Ann Arbor, MI
3University of Pittsburgh, Pittsburgh
4University of Minnesota, Minneapolis
5Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA

*signifies non-member of ASH